Canada NewsWire
HALIFAX, Dec. 10, 2018
HALIFAX, Dec. 10, 2018 /CNW/ - Adaptiiv Medical Technologies Inc. (Adaptiiv), an innovative medical technology company, announced today the release of its most significant advancement to date of its medical software, 3D Bolus 2.0. This release includes numerous updates to existing features based on client feedback, as well as new features such as;
"This is an exciting time for our organization," said Adaptiiv CTO, Alex Dunphy. "Adaptiiv is the first company in the world to receive FDA 510k clearance for 3D printing software used in radiation oncology. Version 2.0 of the 3D Bolus Software was built by gathering and analyzing feedback from our customers in order to develop a product that meets day-to-day clinical needs. 3D Bolus 2.0 enables our customers to improve the standard of care they provide to the patients, through the 3D printing of patient-specific accessories."
About Adaptiiv
Adaptiiv Medical Technologies Inc. (formerly 3D Bolus Inc.) is the definitive 3D technology platform for radiation oncology. Headquartered in Halifax, Nova Scotia, Canada, Adaptiiv is shaping the future of patient-specific healthcare through innovation and collaboration with leading Cancer Centres throughout the world. Adaptiiv has 510(k) clearance, is ISO 13485 certified and has received CE Mark.
Website: http://www.adaptiiv.com/
View original content to download multimedia:http://www.prnewswire.com/news-releases/adaptiiv-announces-major-release-300762884.html
SOURCE Adaptiiv Medical Technologies Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/10/c4042.html